Report Detail

According to our (Global Info Research) latest study, the global Europium Nanoparticle for Tumor Marker Testing market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
In 2025, the global production of Europium Nanoparticles for Tumor Marker Testing reached approximately 6.8 tons, with an average selling price of approximately US$385,000 per ton, production capacity of approximately 9.7 tons, and a gross margin of approximately 51.0%.
Tumor marker fluorescence testing is a diagnostic method that involves the use of fluorescent dyes, which can attach to specific types of tumor markers (proteins produced by cancer cells or other cells in response to cancer). This technique allows for more precise detection and localization of cancerous cells within the body.
Europium (Eu) is a rare earth element that can be used in the detection of tumor markers due to its unique luminescence properties.
The global Europium Nanoparticle for Tumor Marker Testing market is a highly specialized segment of upstream fluorescent labeling materials for in-vitro diagnostics. Demand primarily comes from manufacturers of tumor marker immunoassay reagents, fluorescence immunochromatographic assays, and POCT products. As tumor marker testing generally requires high sensitivity, quantitative capability, batch-to-batch consistency, and signal stability, europium nanoparticles offer significant application value in selected high-sensitivity immunoassay systems due to their time-resolved fluorescence characteristics, high signal-to-noise ratios, and broad detection dynamic ranges. Growing demand for cancer screening, auxiliary diagnosis, treatment monitoring, and decentralized or point-of-care testing is expected to support continued demand for these fluorescent materials. However, the market also faces competition from chemiluminescence immunoassays, conventional fluorescent labels, and other rare-earth fluorescent materials.
Report Scope
This report is a detailed and comprehensive analysis for global Europium Nanoparticle for Tumor Marker Testing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Europium Nanoparticle for Tumor Marker Testing market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Europium Nanoparticle for Tumor Marker Testing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Europium Nanoparticle for Tumor Marker Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Europium Nanoparticle for Tumor Marker Testing market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Europium Nanoparticle for Tumor Marker Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Europium Nanoparticle for Tumor Marker Testing market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck, Bangs Laboratories, Inc., Suzhou NanoMicro Technology Co, Polysciences Inc, CD Bioparticles, Hangzhou Bioeast Biotech Co, Nanjing Microoetection, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Europium Nanoparticle for Tumor Marker Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
300 nm
200 nm
100 nm
Other
Market segment by Material Structure
Europium-Doped Nanoparticles
Europium Chelate Nanoparticles
Europium Coordination Polymer Nanoparticles
Others
Market segment by Surface Functionalization
Carboxyl-Functionalized
Amino-Functionalized
Streptavidin-Functionalized
Other Functionalization
Market segment by Application
Biopharmaceutical Companies
Laboratories and Research Institutions
Other
Major players covered
Thermo Fisher Scientific
Merck
Bangs Laboratories, Inc.
Suzhou NanoMicro Technology Co
Polysciences Inc
CD Bioparticles
Hangzhou Bioeast Biotech Co
Nanjing Microoetection
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Europium Nanoparticle for Tumor Marker Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Europium Nanoparticle for Tumor Marker Testing, with price, sales quantity, revenue, and global market share of Europium Nanoparticle for Tumor Marker Testing from 2021 to 2026.
Chapter 3, the Europium Nanoparticle for Tumor Marker Testing competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Europium Nanoparticle for Tumor Marker Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Europium Nanoparticle for Tumor Marker Testing market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Europium Nanoparticle for Tumor Marker Testing.
Chapter 14 and 15, to describe Europium Nanoparticle for Tumor Marker Testing sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Europium Nanoparticle for Tumor Marker Testing Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 300 nm
    • 1.3.3 200 nm
    • 1.3.4 100 nm
    • 1.3.5 Other
  • 1.4 Market Analysis by Material Structure
    • 1.4.1 Overview: Global Europium Nanoparticle for Tumor Marker Testing Consumption Value by Material Structure: 2021 Versus 2025 Versus 2032
    • 1.4.2 Europium-Doped Nanoparticles
    • 1.4.3 Europium Chelate Nanoparticles
    • 1.4.4 Europium Coordination Polymer Nanoparticles
    • 1.4.5 Others
  • 1.5 Market Analysis by Surface Functionalization
    • 1.5.1 Overview: Global Europium Nanoparticle for Tumor Marker Testing Consumption Value by Surface Functionalization: 2021 Versus 2025 Versus 2032
    • 1.5.2 Carboxyl-Functionalized
    • 1.5.3 Amino-Functionalized
    • 1.5.4 Streptavidin-Functionalized
    • 1.5.5 Other Functionalization
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Europium Nanoparticle for Tumor Marker Testing Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Biopharmaceutical Companies
    • 1.6.3 Laboratories and Research Institutions
    • 1.6.4 Other
  • 1.7 Global Europium Nanoparticle for Tumor Marker Testing Market Size & Forecast
    • 1.7.1 Global Europium Nanoparticle for Tumor Marker Testing Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Europium Nanoparticle for Tumor Marker Testing Sales Quantity (2021-2032)
    • 1.7.3 Global Europium Nanoparticle for Tumor Marker Testing Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Europium Nanoparticle for Tumor Marker Testing Product and Services
    • 2.1.4 Thermo Fisher Scientific Europium Nanoparticle for Tumor Marker Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Europium Nanoparticle for Tumor Marker Testing Product and Services
    • 2.2.4 Merck Europium Nanoparticle for Tumor Marker Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck Recent Developments/Updates
  • 2.3 Bangs Laboratories, Inc.
    • 2.3.1 Bangs Laboratories, Inc. Details
    • 2.3.2 Bangs Laboratories, Inc. Major Business
    • 2.3.3 Bangs Laboratories, Inc. Europium Nanoparticle for Tumor Marker Testing Product and Services
    • 2.3.4 Bangs Laboratories, Inc. Europium Nanoparticle for Tumor Marker Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Bangs Laboratories, Inc. Recent Developments/Updates
  • 2.4 Suzhou NanoMicro Technology Co
    • 2.4.1 Suzhou NanoMicro Technology Co Details
    • 2.4.2 Suzhou NanoMicro Technology Co Major Business
    • 2.4.3 Suzhou NanoMicro Technology Co Europium Nanoparticle for Tumor Marker Testing Product and Services
    • 2.4.4 Suzhou NanoMicro Technology Co Europium Nanoparticle for Tumor Marker Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Suzhou NanoMicro Technology Co Recent Developments/Updates
  • 2.5 Polysciences Inc
    • 2.5.1 Polysciences Inc Details
    • 2.5.2 Polysciences Inc Major Business
    • 2.5.3 Polysciences Inc Europium Nanoparticle for Tumor Marker Testing Product and Services
    • 2.5.4 Polysciences Inc Europium Nanoparticle for Tumor Marker Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Polysciences Inc Recent Developments/Updates
  • 2.6 CD Bioparticles
    • 2.6.1 CD Bioparticles Details
    • 2.6.2 CD Bioparticles Major Business
    • 2.6.3 CD Bioparticles Europium Nanoparticle for Tumor Marker Testing Product and Services
    • 2.6.4 CD Bioparticles Europium Nanoparticle for Tumor Marker Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 CD Bioparticles Recent Developments/Updates
  • 2.7 Hangzhou Bioeast Biotech Co
    • 2.7.1 Hangzhou Bioeast Biotech Co Details
    • 2.7.2 Hangzhou Bioeast Biotech Co Major Business
    • 2.7.3 Hangzhou Bioeast Biotech Co Europium Nanoparticle for Tumor Marker Testing Product and Services
    • 2.7.4 Hangzhou Bioeast Biotech Co Europium Nanoparticle for Tumor Marker Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hangzhou Bioeast Biotech Co Recent Developments/Updates
  • 2.8 Nanjing Microoetection
    • 2.8.1 Nanjing Microoetection Details
    • 2.8.2 Nanjing Microoetection Major Business
    • 2.8.3 Nanjing Microoetection Europium Nanoparticle for Tumor Marker Testing Product and Services
    • 2.8.4 Nanjing Microoetection Europium Nanoparticle for Tumor Marker Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Nanjing Microoetection Recent Developments/Updates

3 Competitive Environment: Europium Nanoparticle for Tumor Marker Testing by Manufacturer

  • 3.1 Global Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Europium Nanoparticle for Tumor Marker Testing Revenue by Manufacturer (2021-2026)
  • 3.3 Global Europium Nanoparticle for Tumor Marker Testing Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Europium Nanoparticle for Tumor Marker Testing by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Europium Nanoparticle for Tumor Marker Testing Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Europium Nanoparticle for Tumor Marker Testing Manufacturer Market Share in 2025
  • 3.5 Europium Nanoparticle for Tumor Marker Testing Market: Overall Company Footprint Analysis
    • 3.5.1 Europium Nanoparticle for Tumor Marker Testing Market: Region Footprint
    • 3.5.2 Europium Nanoparticle for Tumor Marker Testing Market: Company Product Type Footprint
    • 3.5.3 Europium Nanoparticle for Tumor Marker Testing Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Europium Nanoparticle for Tumor Marker Testing Market Size by Region
    • 4.1.1 Global Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Europium Nanoparticle for Tumor Marker Testing Consumption Value by Region (2021-2032)
    • 4.1.3 Global Europium Nanoparticle for Tumor Marker Testing Average Price by Region (2021-2032)
  • 4.2 North America Europium Nanoparticle for Tumor Marker Testing Consumption Value (2021-2032)
  • 4.3 Europe Europium Nanoparticle for Tumor Marker Testing Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Europium Nanoparticle for Tumor Marker Testing Consumption Value (2021-2032)
  • 4.5 South America Europium Nanoparticle for Tumor Marker Testing Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Europium Nanoparticle for Tumor Marker Testing Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Type (2021-2032)
  • 5.2 Global Europium Nanoparticle for Tumor Marker Testing Consumption Value by Type (2021-2032)
  • 5.3 Global Europium Nanoparticle for Tumor Marker Testing Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Application (2021-2032)
  • 6.2 Global Europium Nanoparticle for Tumor Marker Testing Consumption Value by Application (2021-2032)
  • 6.3 Global Europium Nanoparticle for Tumor Marker Testing Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Type (2021-2032)
  • 7.2 North America Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Application (2021-2032)
  • 7.3 North America Europium Nanoparticle for Tumor Marker Testing Market Size by Country
    • 7.3.1 North America Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Europium Nanoparticle for Tumor Marker Testing Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Type (2021-2032)
  • 8.2 Europe Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Application (2021-2032)
  • 8.3 Europe Europium Nanoparticle for Tumor Marker Testing Market Size by Country
    • 8.3.1 Europe Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Europium Nanoparticle for Tumor Marker Testing Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Europium Nanoparticle for Tumor Marker Testing Market Size by Region
    • 9.3.1 Asia-Pacific Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Europium Nanoparticle for Tumor Marker Testing Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Type (2021-2032)
  • 10.2 South America Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Application (2021-2032)
  • 10.3 South America Europium Nanoparticle for Tumor Marker Testing Market Size by Country
    • 10.3.1 South America Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Europium Nanoparticle for Tumor Marker Testing Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Europium Nanoparticle for Tumor Marker Testing Market Size by Country
    • 11.3.1 Middle East & Africa Europium Nanoparticle for Tumor Marker Testing Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Europium Nanoparticle for Tumor Marker Testing Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Europium Nanoparticle for Tumor Marker Testing Market Drivers
  • 12.2 Europium Nanoparticle for Tumor Marker Testing Market Restraints
  • 12.3 Europium Nanoparticle for Tumor Marker Testing Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Europium Nanoparticle for Tumor Marker Testing and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Europium Nanoparticle for Tumor Marker Testing
  • 13.3 Europium Nanoparticle for Tumor Marker Testing Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Europium Nanoparticle for Tumor Marker Testing Typical Distributors
  • 14.3 Europium Nanoparticle for Tumor Marker Testing Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Thermo Fisher Scientific Merck Bangs Laboratories, Inc. Suzhou NanoMicro Technology Co Polysciences Inc CD Bioparticles Hangzhou Bioeast Biotech Co Nanjing Microoetection. Industry analysis & Market Report on Thermo Fisher Scientific Merck Bangs Laboratories, Inc. Suzhou NanoMicro Technology Co Polysciences Inc CD Bioparticles Hangzhou Bioeast Biotech Co Nanjing Microoetection is a syndicated market report, published as Global Europium Nanoparticle for Tumor Marker Testing Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Thermo Fisher Scientific Merck Bangs Laboratories, Inc. Suzhou NanoMicro Technology Co Polysciences Inc CD Bioparticles Hangzhou Bioeast Biotech Co Nanjing Microoetection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report